Artal Group S.A. - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 75 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$426,000
-80.0%
60,697
-59.5%
0.01%
-66.7%
Q1 2018$2,135,000
+62.5%
150,0000.0%0.03%
+35.0%
Q4 2017$1,314,000
-26.6%
150,000
-1.9%
0.02%
-35.5%
Q3 2017$1,789,000
-57.3%
152,920
-49.0%
0.03%
-57.5%
Q2 2017$4,191,000
+52.7%
300,000
+50.0%
0.07%
+19.7%
Q1 2017$2,744,000200,0000.06%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Kynam Capital Management, LP 956,165$20,930,00011.19%
Aisling Capital Management LP 1,025,000$22,437,0007.92%
FRAZIER MANAGEMENT LLC 2,772,062$60,680,0004.67%
SPHERA FUNDS MANAGEMENT LTD. 1,176,585$25,755,0002.83%
Paradigm Biocapital Advisors LP 453,091$9,918,0002.83%
Ghost Tree Capital, LLC 300,000$6,567,0002.35%
Avidity Partners Management LP 4,823,400$105,584,0002.24%
Nantahala Capital Management 2,850,559$62,399,0002.20%
ACUTA CAPITAL PARTNERS, LLC 206,126$4,512,0001.90%
BVF INC/IL 2,099,714$45,963,0001.67%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders